For epididymitis in a patient younger than 35 years, what is the recommended treatment?

The recommended treatment for epididymitis in a patient younger than 35 years is indeed to use ceftriaxone combined with doxycycline. This is a standard approach because in younger men, the most common infectious causes of epididymitis are sexually transmitted infections, particularly those caused by Neisseria gonorrhoeae and Chlamydia trachomatis.

Ceftriaxone is a broad-spectrum cephalosporin antibiotic effective against gonococcal infections, providing coverage for Neisseria gonorrhoeae. Doxycycline, on the other hand, is a tetracycline antibiotic that is effective against Chlamydia trachomatis. This dual therapy effectively addresses both potential pathogens that are prevalent in this age group, ensuring comprehensive treatment and reducing the risk of complications.

Considering the other options, fluoroquinolones alone could be used for treating uncomplicated urinary tract infections or when there is a concern for other causes of epididymitis in older patients or in specific scenarios where STI is less likely. Doxycycline alone does not provide coverage for gonorrhea, which is critical in this population. Lastly, while combining ciprofloxacin and azithromycin might cover both organisms, azithromycin is not typically